Reevaluating Beta Blockers' Role in Heart Attack Treatment
TL;DR Summary
The REBOOT trial found that beta blockers, a standard treatment for heart attack patients with preserved heart function, offer no significant benefit and may increase risks for women, potentially leading to a change in clinical guidelines worldwide.
Topics:top-news#beta-blockers#cardiovascular-treatment#health#heart-attack#reboot-trial#women-outcomes
- Beta blockers may offer no benefit for heart attack patients, and women can have worse outcomes Medical Xpress
- Common heart attack drug doesn’t work and may raise risk of death for some women, new studies say CNN
- Does a common heart attack pill help everyone? Studies disagree Reuters
- Doctors may need to rethink decades of routine beta blocker use for some patients after a heart attack, studies suggest ABC News
- Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF TCTMD.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
4 min
vs 5 min read
Condensed
95%
822 → 37 words
Want the full story? Read the original article
Read on Medical Xpress